Full name
GENEAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GENEAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. DR. STEFANA KOPCIŃSKIEGO 16/18 / 904, 90-232 ŁÓDŹ
TAX ID7262657615
Rate company:
GENEAMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7262657615
KRS0000575960
Share capital20,550.00 zł
address
UL. DR. STEFANA KOPCIŃSKIEGO 16/18 / 904, 90-232 ŁÓDŹ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7262657615
REGON
362501747
KRS
0000575960
Legal form
limited liability company
Register Address
UL. DR. STEFANA KOPCIŃSKIEGO 16/18 / 904, 90-232 ŁÓDŹ
Date of registration in KRS
2015-09-16
Date of commencement of economic activity
2015-09-16
Act signature
RDF/607850/24/742
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
32.50.Z - Manufacture of medical and dental instruments and supplies
46.46.Z - Wholesale of pharmaceutical goods
47.73.Z - Dispensing chemist in specialised stores
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -33,4 | -8,8 | -8,6 | 2,9 |
EBITDA | -27,2 | -2,7 | -2,4 | 9,5 |
Short time liabilities | 2,6 | 2,6 | 2,6 | 0 |
Equity capital | 80,2 | 71,3 | 62,8 | -12 |
Operating profit (EBIT) | -33,4 | -8,8 | -8,6 | 2,9 |
Assets | 82,7 | 73,9 | 65,3 | -11,6 |
Net profit (loss) | -33,4 | -8,8 | -8,6 | 2,9 |
Cash | 3,1 | 2,9 | 0,5 | -83,4 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 2,6 | 2,6 | 2,6 | 0 |
Working assets | 5,5 | 2,9 | 0,5 | -83,4 |
Depreciation | 6,2 | 6,2 | 6,2 | 0 |
% | % | % | p.p. | |
Profitability of capital | -41,6 | -12,4 | -13,7 | -1,3 |
Equity capital to total assets | 96,9 | 96,5 | 96,1 | -0,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 2.1665046215057373 | 1.1271528005599976 | 0.18684667348861694 | -0,9 |
Net dept to EBITDA | 0.11223546415567398 | 1.0844770669937134 | 0.19870837032794952 | -0,9 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download docx01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Bartosz Wasąg
Gdańsk
India Gold sp. z o.o.
Warszawa
Molecular Biotech Mateusz Gielata
Warszawa
Sandra Cytacka
WARZYMICE
KAROLINA BADORA
Romanówka